How Is Cooper Companies' Stock Performance Compared to Other Medical Instruments & Supplies Stocks?

With a market cap of $10.2 billion, The Cooper Companies, Inc. (COO) is a global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a leading contact lens company, while CooperSurgical focuses on fertility and women’s healthcare, supporting women, babies, and families during critical healthcare moments. 

Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Cooper Companies fits this criterion perfectly. Cooper Companies employs more than 15,000 people, sells products in over 130 countries, and positively impacts more than 50 million lives each year.

Shares of the San Ramon, California-based company have declined 39.3% from its 52-week high of $89.83. COO stock has fallen 16.6% over the past three months, underperforming the First Trust Indxx Global Medical Devices ETF’s (MDEV) nearly 11% increase over the same time frame. 

COO stock is down 32.9% on a YTD basis, lagging behind MDEV’s 2.4% drop. In the longer term, shares of the surgical and contact lens products maker have decreased 18.2% over the past 52 weeks, compared to MDEV’s 1.1% return over the same time frame.

The stock has been trading below its 50-day and 200-day moving averages since late August. 

Cooper Companies shares tumbled 14.7% following its Q3 2026 results on Sept. 9 as the company reported weaker-than-expected revenue of $1.07 billion, mainly due to weak contact-lens demand and reduced U.S. channel inventory. Cooper also cut its fiscal 2026 adjusted EPS forecast to $4.51 - $4.55 and lowered its revenue outlook to $4.23 billion - $4.25 billion, below analysts’ estimates. 

The pressure was concentrated in CooperVision, where Q3 revenue fell to $717 million, with the company warning that lower U.S. channel inventory would continue weighing on results in the next quarter, despite adjusted Q3 EPS of $1.15 beating the estimate.

In comparison, rival Intuitive Surgical, Inc. (ISRG) has shown a less pronounced decline than COO stock. Shares of Intuitive Surgical have dropped 31.4% on a YTD basis and 10.9% over the past 52 weeks. 

Due to the stock’s underperformance, analysts remain cautious on Cooper Companies. The stock has a consensus rating of “Hold” from 18 analysts in coverage, and the mean price target of $70.44 is a premium of 29.1% to current levels.

On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.